IL112557A - Peptides that are VIP antagonists and pharmaceutical compositions comprising them - Google Patents

Peptides that are VIP antagonists and pharmaceutical compositions comprising them

Info

Publication number: IL112557A
Authority: IL; Israel
Prior art keywords: vip; peptides; pharmaceutical compositions; relates; vip antagonists
Prior art date: 1994-02-07

Application number

IL11255795A

Other languages

English (en)

Other versions

IL112557A0 (en

Inventor

Illana Gozes

Douglas E Brenneman

Terry W Moody

Original Assignee

Univ Ramot

Yeda Res & Dev

Secretary Of The Dept Of Healt

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-02-07

Filing date

1995-02-06

Publication date

2000-02-17

1995-02-06 Application filed by Univ Ramot, Yeda Res & Dev, Secretary Of The Dept Of Healt filed Critical Univ Ramot

1995-05-26 Publication of IL112557A0 publication Critical patent/IL112557A0/xx

2000-02-17 Publication of IL112557A publication Critical patent/IL112557A/xx

Links

102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
239000005557 antagonist Substances 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title abstract 2
108010003205 Vasoactive Intestinal Peptide Proteins 0.000 abstract 5
102400000015 Vasoactive intestinal peptide Human genes 0.000 abstract 5
VBUWHHLIZKOSMS-RIWXPGAOSA-N invicorp Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=C(O)C=C1 VBUWHHLIZKOSMS-RIWXPGAOSA-N 0.000 abstract 5
230000000694 effects Effects 0.000 abstract 2
230000032823 cell division Effects 0.000 abstract 1
230000005062 synaptic transmission Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- C07K7/083—Neurotensin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Vascular Medicine (AREA)
Engineering & Computer Science (AREA)
Gastroenterology & Hepatology (AREA)
Endocrinology (AREA)
Zoology (AREA)
Toxicology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

IL11255795A 1994-02-07 1995-02-06 Peptides that are VIP antagonists and pharmaceutical compositions comprising them IL112557A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US08/194,591 US5565424A (en)	1994-02-07	1994-02-07	Superactive VIP antagonists

Publications (2)

Publication Number	Publication Date
IL112557A0 IL112557A0 (en)	1995-05-26
IL112557A true IL112557A (en)	2000-02-17

Family

ID=22718168

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL11255795A IL112557A (en)	1994-02-07	1995-02-06	Peptides that are VIP antagonists and pharmaceutical compositions comprising them

Country Status (11)

Country	Link
US (1)	US5565424A (fr)
EP (1)	EP0738280B1 (fr)
JP (1)	JP3588119B2 (fr)
AT (1)	ATE199160T1 (fr)
AU (1)	AU697829B2 (fr)
CA (1)	CA2182795C (fr)
DE (1)	DE69520092T2 (fr)
DK (1)	DK0738280T3 (fr)
ES (1)	ES2155886T3 (fr)
IL (1)	IL112557A (fr)
WO (1)	WO1995021194A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5849261A (en) *	1991-02-08	1998-12-15	Diatide, Inc.	Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
US6492330B1 (en) *	1996-08-16	2002-12-10	National Institute Of Immunology	Antiangiogenic drugs
US6156725A (en) *	1996-08-16	2000-12-05	National Institute Of Immunology	Drug for the treatment of cancer
EP0835662B1 (fr) *	1996-10-08	2001-11-14	National Institute of Immunology	Médicament pour le traitement du cancer
US20020099003A1 (en) *	1997-10-28	2002-07-25	Wilson Leland F.	Treatment of female sexual dysfunction with vasoactive agents, particularly vasoactive intestinal polypeptide and agonists thereof
CA2346866A1 (fr) *	1998-10-16	2000-04-27	The Government Of The United States Of America As Represented By The Sec Retary Of The Department Of Health And Human Services	Therapie combinee avec antagoniste du polypeptide vasoactif intestinal
EP1257575B1 (fr)	2000-02-18	2007-02-28	Dabur Research Foundation	Analogues radiomarques de peptide intestinal vasoactif destines au diagnostic et a la radiotherapie
US6489297B1 (en)	2000-02-18	2002-12-03	Dabur Research Foundation	Vasoactive intestinal peptide analogs
EP1409519A1 (fr) *	2000-07-31	2004-04-21	Dabur Research Foundation	Conjugue lipides-peptides pour le traitement du cancer
US6828304B1 (en)	2000-07-31	2004-12-07	Dabur Research Foundation	Peptides for treatment of cancer
US20060075968A1 (en) *	2004-10-12	2006-04-13	Applied Materials, Inc.	Leak detector and process gas monitor
AU2012259470B2 (en)	2011-02-02	2017-01-12	Emory University	Antagonism of the VIP signaling pathway
US9458217B2 (en) *	2013-12-05	2016-10-04	Emory University	Methods of managing graft versus host disease
EP4261277A3 (fr)	2016-04-08	2024-01-03	Emory University	Méthodes de traitement du cancer et de maladies infectieuses à l'aide de thérapies à base de cellules
WO2019094817A1 (fr)	2017-11-10	2019-05-16	Emory University	Nanoparticules conjuguées à des antagonistes peptidiques intestinaux vasoactifs
WO2019209952A2 (fr)	2018-04-23	2019-10-31	Emory University	Antagonistes de vip et leurs utilisations dans le traitement du cancer
WO2020102694A1 (fr) *	2018-11-15	2020-05-22	Emory University	Compositions et utilisations d'antagonistes de peptide intestinal vasoactif (vip)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4734400A (en) *	1984-10-09	1988-03-29	Hoffmann-La Roche Inc.	Synthetic vasoactive intestinal peptide analogs
US4605641A (en) *	1984-10-09	1986-08-12	Hoffmann-La Roche Inc.	Synthetic vasoactive intestinal peptide analogs
US5196315A (en) *	1990-05-01	1993-03-23	The Johns Hopkins University	Human neuronal cell line
DK0463450T3 (da) *	1990-06-26	1994-06-27	Sanwa Kagaku Kenkyusho Co	Vasoaktive intestinale polypeptid-analoger og udnyttelsen heraf
US5217953A (en) *	1990-11-30	1993-06-08	The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services	Vasoactive intestinal peptide antagonist
US5273963A (en) *	1991-03-29	1993-12-28	The George Washington University	Compositions and methods for treating small cell and nonsmall cell lung cancers
IL99924A (en) *	1991-10-31	1995-12-31	Yeda Res & Dev	Derivatives of structurally modified vip and pharmaceutical compositions containing them

1994
- 1994-02-07 US US08/194,591 patent/US5565424A/en not_active Expired - Lifetime
1995
- 1995-02-06 IL IL11255795A patent/IL112557A/xx not_active IP Right Cessation
- 1995-02-06 DK DK95909489T patent/DK0738280T3/da active
- 1995-02-06 AT AT95909489T patent/ATE199160T1/de not_active IP Right Cessation
- 1995-02-06 WO PCT/US1995/001496 patent/WO1995021194A1/fr not_active Ceased
- 1995-02-06 ES ES95909489T patent/ES2155886T3/es not_active Expired - Lifetime
- 1995-02-06 DE DE69520092T patent/DE69520092T2/de not_active Expired - Fee Related
- 1995-02-06 AU AU17438/95A patent/AU697829B2/en not_active Ceased
- 1995-02-06 EP EP95909489A patent/EP0738280B1/fr not_active Expired - Lifetime
- 1995-02-06 CA CA002182795A patent/CA2182795C/fr not_active Expired - Fee Related
- 1995-02-06 JP JP52080495A patent/JP3588119B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP0738280B1 (fr)	2001-02-14
WO1995021194A1 (fr)	1995-08-10
CA2182795A1 (fr)	1995-08-10
DE69520092T2 (de)	2001-08-02
US5565424A (en)	1996-10-15
JP3588119B2 (ja)	2004-11-10
AU1743895A (en)	1995-08-21
ES2155886T3 (es)	2001-06-01
CA2182795C (fr)	2007-11-06
DK0738280T3 (da)	2001-09-17
IL112557A0 (en)	1995-05-26
EP0738280A1 (fr)	1996-10-23
JPH09511494A (ja)	1997-11-18
ATE199160T1 (de)	2001-02-15
AU697829B2 (en)	1998-10-15
DE69520092D1 (de)	2001-03-22

Legal Events

Date	Code	Title
2000-06-29	FF	Patent granted
2000-10-31	KB	Patent renewed
2001-07-24	KB	Patent renewed
2006-01-15	MM9K	Patent not in force due to non-payment of renewal fees

Publication	Publication Date	Title
IL112557A (en)	2000-02-17	Peptides that are VIP antagonists and pharmaceutical compositions comprising them
SI0984982T1 (en)	2002-02-28	Lh-rh peptide analogues, their uses and pharmaceutical compositions containing them
NL194828B (nl)	2002-12-02	Somatostatinepeptiden, alsmede dergelijke somatostatinepeptiden bevattende farmaceutische preparaten.
HUP0100266A3 (en)	2003-07-28	1-amino-alkylcyclohexane nmda receptor antagonists, pharmaceutical compositions containing the compounds and their preparations
ZA975533B (en)	1998-01-29	Cyclosporin-containing pharmaceutical composition.
IL142905A0 (en)	2002-04-21	Functional antagonists of hedgehog activity
PH31059A (en)	1998-02-05	Pharmaceutical compositions comprising cyclosporins.
HUP0103265A3 (en)	2002-09-30	Cyclic prosaposin-derived peptides, pharmaceutical compositions comprising thereof and their use
IL70944A (en)	1990-11-29	Octapeptide vasopressin antagonists,their preparation and pharmaceutical compositions comprising them
AUPP589598A0 (en)	1998-10-08	Novel peptides
NZ305735A (en)	1999-01-28	Cyclic peptide antifungal agents, preparation and pharmaceutical compositions thereof
HRP950612B1 (en)	2003-12-31	PEPTIDE p277 ANALOGS, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM
EP0644769A4 (fr)	1995-08-09	Peptides biologiquement actifs presentant des substitutions n-terminales.
FI954986L (fi)	1995-10-19	Uudet, suun kautta annettavat, syklosporiinia sisältävät farmaseuttiset valmisteet
IL139604A (en)	2010-12-30	Fibrinogen-beta chain derived peptide, compositions comprising same and use thereof
ZA9710254B (en)	1998-05-28	LH-RH peptide analogues, their uses and pharmaceutical composition containing them.
BG102514A (en)	1999-04-30	New lh-rh-antagonists of improved effect
DE69434151D1 (de)	2004-12-30	Therapeutische inhaltsstoffe
IL92441A (en)	1993-05-13	Imidazole containing peptides, their preparation and pharmaceutical compositions containing them
WO1999025732A3 (fr)	1999-09-02	Conception, par derivation de dimeres bispirales, d'antagonistes des recepteurs specifiques de cytokines en faisceau de quatre helices
EP0154544A3 (fr)	1988-10-05	Antagonistes de de-proline vasopressine
IL127565A0 (en)	1999-10-28	Virginiamycin mixture
AU2387592A (en)	1993-03-02	Cyclic hexapeptides as tachyquinin antagonists, their preparation and pharmaceutical compositions thereof
ZA9711158B (en)	1998-06-15	Structurally modified peptides that are resistant to peptidase degradation.
ZA981891B (en)	1999-09-06	Peptides useful as somatostatin antagonists.